June 10, 2022
6 min watch
Save
VIDEO: Gauthier discusses new algorithm to detect kidney transplant rejection
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Philippe Gauthier, MD, a transplant nephrologist and senior medical director of organ health at Natera, discusses a two-threshold algorithm that uses donor-derived cell-free DNA and quantity to detect transplant rejection.
“Cell-free DNA is a great technology, and it’s increasingly clear that it is a useful tool in your toolkit,” Gauthier said.
He discusses the clinical importance of the Trifecta study presented at the American Transplant Congress and the strong association his team identified between donor-derived cell-free DNA and molecular rejection. Gauthier and colleagues plan to publish more research on the topic.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Gauthier reports working for and having stocks in Natera.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.